Skip to main content
Back
Watch Compare

NextCure, Inc.

Data quality: 83%
NXTC
NASDAQ Manufacturing Chemicals
$11.64
▲ $0.43 (3.84%)
Mkt Cap: 40.86 M
Price
$11.48
Mkt Cap
40.86 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -50.09 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-209.58%
Below sector avg (-54.01%)
ROIC-138.93%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio2.97
Interest CoverageN/A

Valuation

PE (TTM|NTM)
-0.73 | -1.84
Above sector avg (-1.49)
P/B Ratio1.73
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -0.7 -1.5
P/B 1.7 1.6
ROE % -209.6 -54.0
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

3 analysts
Buy
Current
$11.64
+51.8%
Target
$17.67
$15.00
$18.00
$20.00
Forecast
Forward P/E -1.84
Forward EPS -$6.31
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$6.31
-$9.15 – -$3.47
 0.0 2
FY2026 -$8.21
-$8.81 – -$7.68
 0.0 3

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$2.29 -$0.81 +64.6%
Q32025 -$3.98 -$3.22 +19.2%
Q22025 -$4.62 -$11.29 -144.6%
Q12025 -$4.80 -$4.68 +2.5%

ETFs Holding This Stock

DLHAX DLHAX
0.03% weight
DLRHX DLRHX
0.03% weight
DLHIX DLHIX
0.03% weight
BRSIX BRSIX
0.02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -55.84 M
ROE -209.58% ROA -127.93%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -50.09 M
ROIC -138.93% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.97
Interest Coverage N/A Asset Turnover N/A
Working Capital 21.65 M Tangible Book Value 23.65 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.73 Forward P/E -1.84
P/B Ratio 1.73 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -122.59%
Market Cap 40.86 M Enterprise Value 33.53 M
Per Share
EPS (Diluted TTM) -19.65 Revenue / Share N/A
FCF / Share -14.07 OCF / Share -13.93
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 89.69%
SBC-Adj. FCF -54.17 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 22.38 M
Net Income -55.84 M -55.65 M -62.72 M -74.73 M -69.39 M
EPS (Diluted) -19.65 -1.99 -2.25 -2.69 -2.51
Gross Profit — — — — —
Operating Income -57.62 M -59.75 M -67.64 M -75.91 M -70.77 M
EBITDA — — — — —
R&D Expenses 44.92 M 41.49 M 47.93 M 54.20 M 50.19 M
SG&A Expenses — — — — —
D&A 2.20 M 2.90 M 3.70 M 4.10 M 4.30 M
Interest Expense — — — — —
Income Tax 0.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 50.18 M 80.86 M 128.04 M 184.16 M 242.39 M
Total Liabilities 15.24 M 15.39 M 13.62 M 16.63 M 9.00 M
Shareholders' Equity 34.94 M 65.47 M 114.42 M 167.53 M 233.39 M
Total Debt — — — 0.0 0.0
Cash & Equivalents 25.98 M 27.73 M 13.08 M 26.63 M 12.34 M
Current Assets 43.75 M 71.81 M 112.73 M 163.98 M 227.82 M
Current Liabilities 10.57 M 9.57 M 6.88 M 9.13 M 6.61 M